Efficacy of cavinton in the treatment of patients with chronic blood flow insufficiency. Russian multicenter clinical-epidemiological program "CALIPSO".
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/21311488
Conclusion of this study
The data analysis of the first 1011 individual medical records revealed the significant decrease of patient's complaints (p<0,001) and severity of neurological symptoms (p<0,05) as well as the improvement in scores on the Tinnetti scale (p<0,001) and the MMSE (p<0,001). The safety profile of the drug was confirmed.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study